Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab

Since the efficacy of ipilimumab on nivolumab-resistant advanced melanoma is extremely low, additional supportive therapy for anti-PD-1 antibody therapy-resistant advanced melanoma is needed. Although several supportive therapies that enhance the antitumor immune response of anti-PD-1 antibodies hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanita, Kayo, Fujimura, Taku, Kambayashi, Yumi, Tsukada, Akira, Sato, Yota, Hashimoto, Akira, Aiba, Setsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869583/
https://www.ncbi.nlm.nih.gov/pubmed/29606949
http://dx.doi.org/10.1159/000487127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869583/
https://www.ncbi.nlm.nih.gov/pubmed/29606949
http://dx.doi.org/10.1159/000487127

Ejemplares similares